RxDoctor Payments Data

Dylan McHaffie, DPM

Podiatrist · Beaver, PANPI 1194388629

Payments from drug & device makers

What this record shows

It is spread thinly across 25 manufacturers, the largest accounting for just 21.8%. Reporting peaked in 2022 at $2,961 and has fallen 63.3% since, to $1,087 in 2025.

$5,542in general payments, 2019–2025

Across 119 payments — averaging $46.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mid-atlantic Surgical Systems, LLC$1K
  • Rock Medical Orthopedics, Inc.$1K
  • Smith+Nephew$977
  • Amgen$559
  • Treace Medical Concepts, Inc.$437
  • Paratek Pharmaceuticals, Inc.$176
  • plus $985 from 19 others

What the payments were for

  • Food & beverage$3,14257%
  • Education$2,40043%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,542 in reported general payments places this provider in the 85th percentile of 445 podiatrist providers in Pennsylvania.

See all podiatrist providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$57,114
Medicare patients
317
Services billed
1,064

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin15$222
Methylprednisolone31$214
Doxycycline Hyclate17$110

Paid to pharmacies, not to this prescriber.

Other podiatrist in Beaver

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →